Gut Microbiota and Bile Acids in Type 2 Diabetes Mellitus

NCT04194515 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-01-27

No results posted yet for this study

Summary

The investigators will evaluate the stool microbiota, serum and fecal bile acid composition, and changes in blood glucose and lipid profile before and after one month of metformin or YH1 treatment.

Conditions

Interventions

DRUG

YH1

YH1 treatment for one month

DRUG

metformin

metformin treatment for one month

Sponsors & Collaborators

  • Chang Gung Memorial Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04194515 on ClinicalTrials.gov